Polygenic Hyperlipidemias and Coronary Artery Disease Risk

dc.contributor.authorRipatti P
dc.contributor.authorRamo JT
dc.contributor.authorMars NJ
dc.contributor.authorFu Y
dc.contributor.authorLin JK
dc.contributor.authorSoderlund S
dc.contributor.authorBenner C
dc.contributor.authorSurakka I
dc.contributor.authorKiiskinen T
dc.contributor.authorHavulinna AS
dc.contributor.authorPalta P
dc.contributor.authorFreimer NB
dc.contributor.authorWiden E
dc.contributor.authorSalomaa V
dc.contributor.authorTukiainen T
dc.contributor.authorPirinen M
dc.contributor.authorPalotie A
dc.contributor.authorTaskinen MR
dc.contributor.authorRipatti S
dc.contributor.authorand on behalf of FinnGen
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=biolääketieteen laitos|en=Institute of Biomedicine|
dc.contributor.organizationfi=iho- ja sukupuolitautioppi|en=Dermatology and Venereology|
dc.contributor.organizationfi=kliininen kemia|en=Clinical Chemistry|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=lääketieteellinen tiedekunta|en=Faculty of Medicine|
dc.contributor.organizationfi=silmätautioppi|en=Ophthalmology|
dc.contributor.organizationfi=sisätautioppi|en=Internal Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.13290506867
dc.contributor.organization-code1.2.246.10.2458963.20.14959157323
dc.contributor.organization-code1.2.246.10.2458963.20.39855016430
dc.contributor.organization-code1.2.246.10.2458963.20.40502528769
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.contributor.organization-code1.2.246.10.2458963.20.77952289591
dc.contributor.organization-code1.2.246.10.2458963.20.93148683050
dc.converis.publication-id52298031
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/52298031
dc.date.accessioned2022-02-25T16:09:27Z
dc.date.available2022-02-25T16:09:27Z
dc.description.abstractBackground:<div>Hyperlipidemia is a highly heritable risk factor for coronary artery disease (CAD). While monogenic familial hypercholesterolemia associates with severely increased CAD risk, it remains less clear to what extent a high polygenic load of a large number of LDL (low-density lipoprotein) cholesterol (LDL-C) or triglyceride (TG)-increasing variants associates with increased CAD risk.<div>Methods:</div><div>We derived polygenic risk scores (PRSs) with approximate to 6M variants separately for LDL-C and TG with weights from a UK Biobank-based genome-wide association study with approximate to 324K samples. We evaluated the impact of polygenic hypercholesterolemia and hypertriglyceridemia to lipid levels in 27 039 individuals from the National FINRISK Study (FINRISK) cohort and to CAD risk in 135 638 individuals (13 753 CAD cases) from the FinnGen project (FinnGen).</div><div>Results:</div><div>In FINRISK, median LDL-C was 3.39 (95% CI, 3.38-3.40) mmol/L, and it ranged from 2.87 (95% CI, 2.82-2.94) to 3.78 (95% CI, 3.71-3.83) mmol/L between the lowest and highest 5% of the LDL-C PRS distribution. Median TG was 1.19 (95% CI, 1.18-1.20) mmol/L, ranging from 0.97 (95% CI, 0.94-1.00) to 1.55 (95% CI, 1.48-1.61) mmol/L with the TG PRS. In FinnGen, comparing the highest 5% of the PRS to the lowest 95%, CAD odds ratio was 1.36 (95% CI, 1.24-1.49) for the LDL-C PRS and 1.31 (95% CI, 1.19-1.43) for the TG PRS. These estimates were only slightly attenuated when adjusting for a CAD PRS (odds ratio, 1.26 [95% CI, 1.16-1.38] for LDL-C and 1.24 [95% CI, 1.13-1.36] for TG PRS).</div><div>Conclusions:</div><div>The CAD risk associated with a high polygenic load for lipid-increasing variants was proportional to their impact on lipid levels and partially overlapping with a CAD PRS. In contrast with a PRS for CAD, the lipid PRSs point to known and directly modifiable risk factors providing additional guidance for clinical translation.</div></div>
dc.format.pagerange59
dc.format.pagerange65
dc.identifier.eissn2574-8300
dc.identifier.jour-issn2574-8300
dc.identifier.olddbid170278
dc.identifier.oldhandle10024/153388
dc.identifier.urihttps://www.utupub.fi/handle/11111/29346
dc.identifier.urlhttps://www.ahajournals.org/doi/10.1161/CIRCGEN.119.002725
dc.identifier.urnURN:NBN:fi-fe2021042820888
dc.language.isoen
dc.okm.affiliatedauthorAaltonen, Vesa
dc.okm.affiliatedauthorElenius, Klaus
dc.okm.affiliatedauthorJuonala, Markus
dc.okm.affiliatedauthorKallio, Lila
dc.okm.affiliatedauthorKarlsson, Antti
dc.okm.affiliatedauthorKoulu, Leena
dc.okm.affiliatedauthorMetsärinne, Kaj
dc.okm.affiliatedauthorPalomäki, Antti
dc.okm.affiliatedauthorPeltonen, Sirkku
dc.okm.affiliatedauthorPirilä, Laura
dc.okm.affiliatedauthorPulkki, Kari
dc.okm.affiliatedauthorRinne, Juha
dc.okm.affiliatedauthorSchleutker, Johanna
dc.okm.affiliatedauthorVirolainen, Petri
dc.okm.affiliatedauthorVoutilainen, Markku
dc.okm.affiliatedauthorDataimport, 2609820 PET Tutkimus
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline3121 Internal medicineen_GB
dc.okm.discipline3121 Sisätauditfi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1161/CIRCGEN.119.002725
dc.relation.ispartofjournalCirculation: Genomic and Precision Medicine
dc.relation.issue2
dc.relation.volume13
dc.source.identifierhttps://www.utupub.fi/handle/10024/153388
dc.titlePolygenic Hyperlipidemias and Coronary Artery Disease Risk
dc.year.issued2020

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
CIRCGEN.119.002725.pdf
Size:
421.02 KB
Format:
Adobe Portable Document Format
Description:
Publishers's PDF